Sign up to save your podcasts
Or
Share Axi-Cel and 5-FU Label Changes
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Axi-Cel and 5-FU Label Changes
We have FDA changes to the labels of Axi-Cel (to allow for its use in primary CNS lymphoma) and 5-flourouracil (pre-treatment DPYD testing).
Also, pembrolizumab nets another approval, this time in conjunction with paclitaxel for platinum-resistant ovarian cancer (limited to PD-L1 CPS of 1% of greater)
View all episodes
By John Bossaer
4.9
185185 ratings
We have FDA changes to the labels of Axi-Cel (to allow for its use in primary CNS lymphoma) and 5-flourouracil (pre-treatment DPYD testing).
Also, pembrolizumab nets another approval, this time in conjunction with paclitaxel for platinum-resistant ovarian cancer (limited to PD-L1 CPS of 1% of greater)
More shows like OncoPharm
View all
JAMA Clinical Reviews
505 Listeners
The Daily
113,527 Listeners
Up First from NPR
56,976 Listeners
Armchair Expert with Dax Shepard
69,619 Listeners
ASCO Guidelines
47 Listeners
The Peter Attia Drive
7,979 Listeners
OncLive® On Air
24 Listeners
Raising Good Humans
1,885 Listeners
Oncology Today with Dr Neil Love
61 Listeners
Huberman Lab
29,295 Listeners
The Money with Katie Show
1,540 Listeners
Two Onc Docs
196 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
47 Listeners
WolverHeme Happy Hour
30 Listeners
Good Hang with Amy Poehler
12,693 Listeners